4//SEC Filing
Silberman David 4
Accession 0001213900-21-046413
CIK 0001176309other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 4:48 PM ET
Size
7.6 KB
Accession
0001213900-21-046413
Insider Transaction Report
Form 4
Silberman David
Chief Financial Officer
Transactions
- Award
Common Stock
2021-09-01+50,000→ 50,000 total - Award
Stock Option (right to buy)
2021-09-01+50,000→ 50,000 totalExercise: $20.19Exp: 2031-09-01→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]Represents common stock underlying Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The RSUs will vest as follows: 33,333 shall vest in three equal installments over a period of three years upon Issuer's common stock achieving a specified price per share, and 16,667 shall vest in three equal installments over a period of three years upon Issuer's achievement of certain business objectives.
- [F3]The Stock Options will vest in four equal installments of 12,500 on each of June 27, 2022, June 27, 2023, June 27, 2024 and June 27, 2025.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001867998
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 4:48 PM ET
- Size
- 7.6 KB